Médecins Sans Frontières-OCG
Massakory, Chad
NCT Number: NCT02085044
The hypothesis for the study is that 12 months of a Ready-To-Use Supplementary Food (RUSF) distributions have a greater impact on children's health than the standard RUSF distributions during the hunger gap period (june to september). We estimated that the 12 month RUSF will decrease the incidence of severe acute malnutrition by 33% compared to an administration only during the hunger gap period (4 month a year).
Looking for future studies?
Notify Me6 month–24 month
All sexes
Interventional
Phase 4
Massakory, Chad
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Plumpy 'doz
Time frame: overall study time, 22 months
Incidence of acute severe malnutrition will be assessed for the overall 2 years.
Estimation if incidence will include children from their entry in the study to their exit of study (disharge as 24 months, dead of Lost of follow up )
Time frame: overall study time 22 months
Mortality will be assessed for the overall 2 years. Estimation will include children from their entry in the study to their exit of study (disharge as 24 months, dead of Lost of follow up )
Time frame: overall study time 22 months
Time frame: 22 months
Time frame: 22 months
France Broillet
Other
Non Randomized Controlled Intervention Study Comparing Two Interventions of Nutritional Supplement on Malnutrition, Health and Mortality in Children Aged 6 to 24 Month Hadjer-Lamis Region - Chad
Acronym: NRCI-ASPE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02911246
Brain Diseases, Brain Injuries
Nantes, France
View Trial DetailsNCT06397118
Anemia, Anemia, Hemolytic
Nashville, Tennessee, United States
View Trial DetailsNCT04244851
Malnutrition, Nutrition Disorders
Rennes, France
View Trial DetailsNCT07620197
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial Details